Raffaele Lopreiato

Dr. Raffaele Lopreiato


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2010 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
VCVeronica Costa
Veronica Costa
Marta GiacomelloMarta Giacomello
Marta Giacomello
RHRoman Hudec
Roman Hudec
RLRaffaele Lopreiato
Raffaele Lopreiato
GEGennady Ermak
Gennady Ermak
Luca ScorranoLuca Scorrano
Luca Scorrano
Huntington9s disease (HD), a genetic neurodegenerative disease caused by a polyglutamine expansion in the Huntingtin (Htt) protein, is accompanied by multiple mitochondrial alterations. Here, we show that mitochondrial fragmentation and cristae alterations characterize cellular models of HD and participate in their increased susceptibility to apoptosis. In HD cells, the increased basal activity of the phosphatase calcineurin dephosphorylates the pro‐fission dynamin related protein 1 (Drp1), increasing its mitochondrial translocation and activation, and ultimately leading to fragmentation of the organelle. The fragmented HD mitochondria are characterized by cristae alterations that are aggravated by apoptotic stimulation. A genetic analysis indicates that correction of mitochondrial elongation is not sufficient to rescue the increased cytochrome c release and cell death observed in HD cells. Conversely, the increased apoptosis can be corrected by manoeuvres that prevent fission and cristae remodelling. In conclusion, the cristae remodelling of the fragmented HD mitochondria contributes to their hypersensitivity to apoptosis. See accompanying Closeup by Oliveira and Lightowlers DOI 10.1002/emmm.201000104.

27 July 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
EKElena Kisseleva‐Romanova
Elena Kisseleva‐Romanova
RLRaffaele Lopreiato
Raffaele Lopreiato
ABAgnès Baudin‐Baillieu
Agnès Baudin‐Baillieu
JRJean‐Claude Rousselle
Jean‐Claude Rousselle
LILaila Ilan
Laila Ilan
DLDomenico Libri
Domenico Libri
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 April 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RLRaffaele Lopreiato
Raffaele Lopreiato
Marta GiacomelloMarta Giacomello
Marta Giacomello
ECErnesto Carafoli
Ernesto Carafoli
The three-dimensional structure of the PMCA pump has not been solved, but its basic mechanistic properties are known to repeat those of the other Ca(2+) pumps. However, the pump also has unique properties. They concern essentially its numerous regulatory mechanisms, the most important of which is the autoinhibition by its C-terminal tail. Other regulatory mechanisms involve protein kinases and the phospholipids of the membrane in which the pump is embedded. Permanent activation of the pump, e.g. by calmodulin, is physiologically as harmful to cells as its absence. The concept is now emerging that the global control of cell Ca(2+) may not be the main function of the pump; in some cell types, it could even be irrelevant. The main pump role would be the regulation of Ca(2+) in cell microdomains in which the pump co-segregates with partners that modulate the Ca(2+) message and transduce it to important cell functions.

23 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
CPCaterina Peggion
Caterina Peggion
Valeria ScalconValeria Scalcon
Valeria Scalcon
MMMaria Lina Massimino
Maria Lina Massimino
KNKelly Nies
Kelly Nies
RLRaffaele Lopreiato
Raffaele Lopreiato
ABAlessandro Bertoli
Alessandro Bertoli
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the loss of motor neurons in the brain and spinal cord. While the exact causes of ALS are still unclear, the discovery that familial cases of ALS are related to mutations in the Cu/Zn superoxide dismutase (SOD1), a key antioxidant enzyme protecting cells from the deleterious effects of superoxide radicals, suggested that alterations in SOD1 functionality and/or aberrant SOD1 aggregation strongly contribute to ALS pathogenesis. A new scenario was opened in which, thanks to the generation of SOD1 related models, different mechanisms crucial for ALS progression were identified. These include excitotoxicity, oxidative stress, mitochondrial dysfunctions, and non-cell autonomous toxicity, also implicating altered Ca2+ metabolism. While most of the literature considers motor neurons as primary target of SOD1-mediated effects, here we mainly discuss the effects of SOD1 mutations in non-neuronal cells, such as glial and skeletal muscle cells, in ALS. Attention is given to the altered redox balance and Ca2+ homeostasis, two processes that are strictly related with each other. We also provide original data obtained in primary myocytes derived from hSOD1(G93A) transgenic mice, showing perturbed expression of Ca2+ transporters that may be responsible for altered mitochondrial Ca2+ fluxes. ALS-related SOD1 mutants are also responsible for early alterations of fundamental biological processes in skeletal myocytes that may impinge on skeletal muscle functions and the cross-talk between muscle cells and motor neurons during disease progression.

7 August 2008 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
AHArnaud Hecker
Arnaud Hecker
RLRaffaele Lopreiato
Raffaele Lopreiato
MGMarc Graille
Marc Graille
BCBruno Collinet
Bruno Collinet
PFPatrick Forterre
Patrick Forterre
HTHerman van Tilbeurgh
Herman van Tilbeurgh
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

15 January 2004 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
RLRaffaele Lopreiato
Raffaele Lopreiato
SFSonia Facchin
Sonia Facchin
GSGeppo Sartori
Geppo Sartori
GAGiorgio Arrigoni
Giorgio Arrigoni
SCStefano Casonato
Stefano Casonato
GCGiovanna Carignani
Giovanna Carignani
The Saccharomyces cerevisiae piD261/Bud32 protein and its structural homologues, which are present along the Archaea–Eukarya lineage, constitute a novel protein kinase family (the piD261 family) distantly related in sequence to the eukaryotic protein kinase superfamily. It has been demonstrated that the yeast protein displays Ser/Thr phosphotransferase activity in vitro and contains all the invariant residues of the family. This novel protein kinase appears to play an important cellular role as deletion in yeast of the gene encoding piD261/Bud32 results in the alteration of fundamental processes such as cell growth and sporulation. In this work we show that the phosphotransferase activity of Bud32 is relevant to its functionality in vivo, but is not the unique role of the protein, since mutants which have lost catalytic activity but not native conformation can partially complement the disruption of the gene encoding piD261/Bud32. A two-hybrid approach has led to the identification of several proteins interacting with Bud32; in particular a glutaredoxin (Grx4), a putative glycoprotease (Ykr038/Kae1) and proteins of the Imd (inosine monophosphate dehydrogenase) family seem most plausible interactors. We further demonstrate that Grx4 directly interacts with Bud32 and that it is phosphorylated in vitro by Bud32 at Ser-134. The functional significance of the interaction between Bud32 and the putative protease Ykr038/Kae1 is supported by its evolutionary conservation.